Tirzepatide 5mg – Dual-Action Support for Diabetes and Weight Loss

Tirzepatide is a cutting-edge peptide originally developed to treat type 2 diabetes. But its benefits go far beyond blood sugar control—it’s also been shown to support cardiovascular health and deliver powerful weight loss effects.

This unique peptide works by mimicking the actions of two key hormones: gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). By activating both receptors, Tirzepatide helps regulate blood glucose, enhances insulin sensitivity, reduces hunger, and promotes a lasting feeling of fullness—all of which contribute to healthy, sustainable weight loss.

How Tirzepatide Works

Tirzepatide is a synthetic analogue of GIP, composed of 39 amino acids. It stimulates the pancreas to release insulin by binding to both GIP and GLP-1 receptors, offering a dual-action approach that’s more effective than targeting one receptor alone.

Over time, Tirzepatide has also been found to increase levels of adiponectin—a hormone linked to improved metabolic health—by up to 26%. This peptide’s combined effects can lead to:

• Improved blood glucose control

• Enhanced insulin sensitivity

• Reduced insulin levels

• Decreased appetite

• Weight loss averaging 11 kg (25 lbs)

• Lowered fat accumulation

• Reduced cardiovascular risk

Peptide Profile

• Amino Acid Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS

• Note: Aib is a non-standard amino acid used to increase peptide stability

• Molecular Formula: CHNO

• Molecular Weight: 4813.527 g/mol

• CAS Number: 2023788-19-2

• PubChem CID: 156588324

• Synonyms: P1206, LY3298176